{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:09:30Z","timestamp":1758046170023,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ancard.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T17:23:08Z","timestamp":1645118588000},"page":"63-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["R\u00f4le de l'imagerie cardiaque dans les cardiomyopathies infiltratives"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-2231","authenticated-orcid":false,"given":"Adrien","family":"Pasteur-Rousseau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Odouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Souibri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic A.","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Deux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ancard.2022.01.001_bib0001","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.ancard.2022.01.001_bib0002","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.recesp.2011.12.015","article-title":"Role of cardiac scintigraphy with 99mTc-DPD in the differentiation of cardiac amyloidosis subtype","volume":"65","author":"de Haro-del Moral","year":"2012","journal-title":"Rev Espanola Cardiol Engl Ed"},{"issue":"6","key":"10.1016\/j.ancard.2022.01.001_bib0003","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ancard.2022.01.001_bib0004","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ancard.2020.09.028","article-title":"[Cardiac CT-Scan: Utility for the management of chest pain, cardiovascular screening and before atrial fibrillation ablation procedure]","volume":"69","author":"Pasteur-Rousseau","year":"2020","journal-title":"Ann Cardiol Angeiol (Paris)."},{"issue":"5","key":"10.1016\/j.ancard.2022.01.001_bib0005","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ancard.2021.08.001","article-title":"[Artificial Intelligence and teleradiology in cardiovascular imaging by CT-Scan and MRI]","volume":"70","author":"Pasteur-Rousseau","year":"2021","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0006","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s00330-017-4984-8","article-title":"Myocardial iodine concentration measurement using dual-energy computed tomography for the diagnosis of cardiac amyloidosis: a pilot study","volume":"28","author":"Chevance","year":"2018","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0007","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ejhf.2028","article-title":"Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis","volume":"23","author":"B\u00e9zard","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.ancard.2022.01.001_bib0008","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.jcmg.2020.06.016","article-title":"Teaching an Old Dog New Tricks: Using Cardiac CT for Comprehensive Imaging","volume":"13","author":"Kalra","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ancard.2022.01.001_bib0009","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of Arrhythmias in Cardiac Amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.ancard.2022.01.001_bib0010","first-page":"58","article-title":"Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis","volume":"20","author":"Ridouani","year":"2018","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0011","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ancard.2022.01.001_bib0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn Reson Med"},{"issue":"5","key":"10.1016\/j.ancard.2022.01.001_bib0013","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ehf2.12511","article-title":"Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis","volume":"6","author":"Brownrigg","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"24","key":"10.1016\/j.ancard.2022.01.001_bib0014","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ancard.2022.01.001_bib0015","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ancard.2022.01.001_bib0016","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jcmg.2016.05.007","article-title":"Early Phase 99Tc-HMDP Scintigraphy for the Diagnosis and Typing of Cardiac Amyloidosis","volume":"10","author":"Galat","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.ancard.2022.01.001_bib0017","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00259-020-04753-7","article-title":"Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT\/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value","volume":"47","author":"Malka","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ancard.2022.01.001_bib0018","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijcard.2017.10.027","article-title":"Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon","volume":"254","author":"Cappelli","year":"2018","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.ancard.2022.01.001_bib0019","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/CRD.0b013e3182a67805","article-title":"Cardiac involvement in hemochromatosis","volume":"22","author":"Gulati","year":"2014","journal-title":"Cardiol Rev"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192890","article-title":"Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment","volume":"13","author":"Torlasco","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.ancard.2022.01.001_bib0022","first-page":"102","article-title":"T1 at 1.5T and 3T compared with conventional T2* at 1.5T for cardiac siderosis","volume":"17","author":"Alam","year":"2015","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"key":"10.1016\/j.ancard.2022.01.001_bib0023","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijcard.2017.06.100","article-title":"Detection of cardiac iron overload with native magnetic resonance T1 and T2 mapping in patients with thalassemia","volume":"248","author":"Krittayaphong","year":"2017","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ancard.2022.01.001_bib0024","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatment in \u03b2-thalassemia major: a consensus statement from the American Heart Association","volume":"128","author":"Pennell","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ancard.2022.01.001_bib0025","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00277-019-03618-w","article-title":"Cardiac complications and iron overload in beta thalassemia major patients-a systematic review and meta-analysis","volume":"98","author":"Koohi","year":"2019","journal-title":"Ann Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.ancard.2022.01.001_bib0026","first-page":"e1","article-title":"Anderson-Fabry disease","volume":"19","author":"Di Toro","year":"2018","journal-title":"J Cardiovasc Med Hagerstown Md"},{"issue":"14","key":"10.1016\/j.ancard.2022.01.001_bib0027","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/01.CIR.98.14.1457","article-title":"Restrictive cardiomyopathy secondary to Fabry's disease","volume":"98","author":"Cantor","year":"1998","journal-title":"Circulation"},{"issue":"7 Pt 1","key":"10.1016\/j.ancard.2022.01.001_bib0028","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jcmg.2018.11.039","article-title":"The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease","volume":"12","author":"Perry","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.ancard.2022.01.001_bib0029","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ancard.2022.01.001_bib0030","first-page":"790","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"4","key":"10.1016\/j.ancard.2022.01.001_bib0031","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.acvd.2019.01.002","article-title":"Fabry disease in cardiology practice: Literature review and expert point of view","volume":"112","author":"Hag\u00e8ge","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0032","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1148\/radiol.2020200909","article-title":"Predictive Value of Cardiac MRI in Patients with Fabry Disease","volume":"296","author":"Tao","year":"2020","journal-title":"Radiology"},{"issue":"23","key":"10.1016\/j.ancard.2022.01.001_bib0033","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ancard.2022.01.001_bib0034","first-page":"479","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.ancard.2022.01.001_bib0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2214\/AJR.05.0442","article-title":"MRI characterization of myocardial tissue in patients with Fabry's disease","volume":"188","author":"Imbriaco","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.ancard.2022.01.001_bib0036","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.2016141802","article-title":"State of the Art: Clinical Applications of Cardiac T1 Mapping","volume":"278","author":"Schelbert","year":"2016","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.ancard.2022.01.001_bib0037","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/a-0836-2723","article-title":"Assessment of Cardiac Involvement in Fabry Disease (FD) with Native T1 Mapping","volume":"191","author":"Roller","year":"2019","journal-title":"ROFO Fortschr Geb Rontgenstr Nuklearmed"},{"issue":"1","key":"10.1016\/j.ancard.2022.01.001_bib0038","first-page":"75","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson Off J Soc Cardiovasc Magn Reson"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diii.2019.08.006","article-title":"Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping","volume":"101","author":"Deborde","year":"2020","journal-title":"Diagn Interv Imaging"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0040","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1148\/radiol.2018172613","article-title":"Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy","volume":"288","author":"Karur","year":"2018","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.ancard.2022.01.001_bib0041","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10554-020-01823-7","article-title":"Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping","volume":"36","author":"R\u00e9ant","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ancard.2022.01.001_bib0042","first-page":"87","article-title":"Diagnosis and Management of Endomyocardial Fibrosis","volume":"35","author":"Beaton","year":"2017","journal-title":"Cardiol Clin"},{"issue":"5","key":"10.1016\/j.ancard.2022.01.001_bib0043","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10741-019-09848-4","article-title":"Endomyocardial fibrosis: past, present, and future","volume":"25","author":"Duraes","year":"2020","journal-title":"Heart Fail Rev"},{"issue":"24","key":"10.1016\/j.ancard.2022.01.001_bib0044","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/CIRCULATIONAHA.115.021178","article-title":"Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives","volume":"133","author":"Grimaldi","year":"2016","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ancard.2022.01.001_bib0045","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.diii.2012.04.019","article-title":"Endomyocardial fibrosis in the context of hypereosinophilic syndrome: the contribution of cardiac MRI","volume":"93","author":"Caudron","year":"2012","journal-title":"Diagn Interv Imaging"},{"issue":"1","key":"10.1016\/j.ancard.2022.01.001_bib0046","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10554-020-01955-w","article-title":"T1 mapping in the assessment of endomyocardial fibrosis","volume":"37","author":"Gonzalez-Bartol","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0047","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ancard.2018.01.001","article-title":"[Tropical endomyocardial fibrosis: Perspectives]","volume":"67","author":"Lachaud","year":"2018","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"11","key":"10.1016\/j.ancard.2022.01.001_bib0048","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11886-019-1244-3","article-title":"Endomyocardial Fibrosis: an Update After 70 Years","volume":"21","author":"Mocumbi","year":"2019","journal-title":"Curr Cardiol Rep"},{"issue":"21","key":"10.1016\/j.ancard.2022.01.001_bib0049","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ancard.2022.01.001_bib0050","first-page":"325","article-title":"Sarcoidosis: a review for the internist","volume":"13","author":"Bargagli","year":"2018","journal-title":"Intern Emerg Med"},{"issue":"9","key":"10.1016\/j.ancard.2022.01.001_bib0051","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-156-9-201205010-01005","article-title":"Sarcoidosis","volume":"156","author":"O'Regan","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ancard.2022.01.001_bib0052","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ancard.2022.01.001_bib0053","doi-asserted-by":"crossref","first-page":"321","DOI":"10.31083\/j.rcm.2020.03.102","article-title":"Cardiac sarcoidosis: diagnosis and management","volume":"21","author":"Markatis","year":"2020","journal-title":"Rev Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.ancard.2022.01.001_bib0054","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.ancard.2022.01.001_bib0055","first-page":"184","article-title":"Diagnosis and treatment of cardiac sarcoidosis","volume":"102","author":"Kusano","year":"2016","journal-title":"Heart Br Card Soc"},{"issue":"1","key":"10.1016\/j.ancard.2022.01.001_bib0056","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12016-015-8475-x","article-title":"Diagnosis of Sarcoidosis","volume":"49","author":"Wessendorf","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.ancard.2022.01.001_bib0057","first-page":"241","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"3","key":"10.1016\/j.ancard.2022.01.001_bib0058","first-page":"657","article-title":"Cardiac sarcoidosis: the challenge of radiologic-pathologic correlation: from the radiologic pathology archives","volume":"35","author":"Jeudy","year":"2015","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"issue":"4","key":"10.1016\/j.ancard.2022.01.001_bib0059","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392822000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392822000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:38:19Z","timestamp":1757716699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392822000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0003392822000397"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2022.01.001","relation":{},"ISSN":["0003-3928"],"issn-type":[{"type":"print","value":"0003-3928"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00f4le de l'imagerie cardiaque dans les cardiomyopathies infiltratives","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}